TENAX THERAPEUTICS, INC. (TENX) › Cash & EquivalentsTENAX THERAPEUTICS, INC. (TENX) — Cash & EquivalentsAnnual figures by period end, from SEC filings.1967-05-25: $02010-04-30: $632.7K2011-04-30: $951.9K2012-04-30: $1.88M2013-04-30: $783.5K2014-04-30: $58.32M2015-04-30: $7.93M2015-12-31: $3.66M2016-12-31: $10.00M2017-12-31: $1.60M2018-12-31: $12.37M2019-12-31: $4.91M2020-12-31: $6.25M2021-12-31: $5.58M2022-12-31: $2.12M2023-12-31: $9.80M2024-12-31: $94.90M2025-12-31: $97.60M$97.60M1967-05-25Cash & Equivalents (USD)2025-12-31Period endedCash & EquivalentsChange YoYSource filing2025-12-31$97.60M+2.8%2026-03-10Balance as of period end2024-12-31$94.90M+868.4%2026-03-10Balance as of period end2023-12-31$9.80M+361.5%2025-03-25Balance as of period end2022-12-31$2.12M-62.0%2023-03-31Balance as of period end2021-12-31$5.58M-10.7%2023-03-31Balance as of period end2020-12-31$6.25M+27.4%2022-03-29Balance as of period end2019-12-31$4.91M-60.3%2021-04-16Balance as of period end2018-12-31$12.37M+670.6%2021-04-16Balance as of period end2017-12-31$1.60M-83.9%2020-03-30Balance as of period end2016-12-31$10.00M+173.1%2019-04-01Balance as of period end2015-12-31$3.66M—2018-04-02Balance as of period end2015-04-30$7.93M-86.4%2017-03-16Balance as of period end2014-04-30$58.32M+7343.3%2017-03-16Balance as of period end2013-04-30$783.5K-58.3%2017-03-16Balance as of period end2012-04-30$1.88M+97.5%2014-07-29Balance as of period end2011-04-30$951.9K+50.5%2013-06-26Balance as of period end2010-04-30$632.7K—2012-07-25Balance as of period end1967-05-25$0—2012-07-25Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)